While Metformin is not a weight loss medication, it can help address one of the underlying metabolic factors that contributes to weight gain in PCOS
For weight management with Wegovy, treatment should be discontinued if less than 5% of initial body weight is lost after 12 weeks on the maintenance dose of 2.4 mg
Lab testing, careful monitoring, and individualized dosing are standard, ensuring safety and effectiveness
PEX-168 improves insulin resistance, inflammatory response and adipokines in simple obese mice: a mechanistic exploration
Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]
List JF, He H, Habener JF